Skip to main content

Stories by Thomas Maeder3 articles archived since 1845

The Orphan Drug Backlash

The Orphan Drug Act of 1983 was supposed to provide incentives for private industry to develop needed, but unprofitable, drugs to treat rare diseases. It has done so, but not without eliciting controversy

May 1, 2003 — Thomas Maeder

Sweet Medicines

Sugars play critical roles in manycellular functions and in disease.Study of those activities lagsbehind research into genes and proteinsbut is beginning to heat up.The discoveries promise to yielda new generation of drug therapies

July 1, 2002 — Thomas Maeder

Celebrate our 170th Anniversary with us!

Get 2 years of All Access for just $170